UNITY Biotechnology Completes Enrollment in Phase 2 ENVISION Study of UBX1325 in Wet Age-related Macular Degeneration
19 sept. 2022 08h00 HE
|
Unity Biotechnology, Inc.
Enrollment of 51 patients exceeds target by ~10% due to high interest in the study 16-week data anticipated in Q1 2023 and 24-week data anticipated in Q2 2023 SOUTH SAN FRANCISCO, Calif., Sept. 19,...
Global Smart Contact Lenses Industry Report 2022-2027: Growth, Trends and Opportunity Forecasts
14 juil. 2022 04h13 HE
|
Research and Markets
Dublin, July 14, 2022 (GLOBE NEWSWIRE) -- The "Smart Contact Lenses Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)" report has been added to ResearchAndMarkets.com's offering....
Global Diabetic Retinopathy Market Is Expected to Reach $10.78 Billion by 2030: Says AMR
14 juin 2022 18h00 HE
|
Allied Market Research
Portland, OR, June 14, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Diabetic Retinopathy Market was estimated at $3.08 billion in 2020 and is...
Global Macular Edema Market Research and Competitive Landscape Report 2021
20 sept. 2021 04h28 HE
|
Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Macular Edema Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Global Macular Edema Market...
Europe Macular Edema Markets and Competitive Landscape Report 2021
10 sept. 2021 03h18 HE
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Europe Macular Edema Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. The latest research Europe...
$213.2 Million Ophthalmic Photocoagulator Global Market to 2028 - Increasing Ophthalmic Disorders is Driving Growth
07 sept. 2021 06h28 HE
|
Research and Markets
Dublin, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Photocoagulator Market Size, Share & Trends Analysis Report by Application (Diabetic Retinopathy, Glaucoma, Macular Edema), by...
Graybug Vision to Participate in SVB Leerink Global Healthcare Conference
17 févr. 2021 07h30 HE
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat...
Graybug Vision Completes Treatment Phase of ALTISSIMO Trial in Wet AMD with 12-Month Topline Data Expected in Second Quarter 2021
07 janv. 2021 07h30 HE
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat...
Outlook on the Uveitis Treatment Global Market to 2025 - Impact of COVID-19 on the Market
18 déc. 2020 05h23 HE
|
Research and Markets
Dublin, Dec. 18, 2020 (GLOBE NEWSWIRE) -- The "Uveitis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Graybug Vision to Participate in the 32nd Annual Piper Sandler Healthcare Conference
16 nov. 2020 16h05 HE
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the...